Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GRI CVE:IMR CVE:NVV NYSE:RTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRIGRI Bio$1.82-6.7%$1.44$1.10▼$43.69$4.54M-1.62158,905 shs242,429 shsIMRiMetal ResourcesC$0.18+5.9%C$0.15C$0.13▼C$0.33C$1.01M1.5939,530 shs1,000 shsNVVNorvista CapitalC$0.08-6.3%C$0.08C$0.07▼C$0.23C$5.26MN/A116,000 shs112,500 shsRTIRTI International Metals$0.00$0.00▼$0.00N/AN/AN/AN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRIGRI Bio0.00%+9.64%+30.00%+20.53%-93.81%IMRiMetal Resources0.00%+28.57%+16.13%-25.00%-30.77%NVVNorvista Capital0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGRIGRI Bio2.3998 of 5 stars3.54.00.00.00.60.01.3IMRiMetal ResourcesN/AN/AN/AN/AN/AN/AN/AN/ANVVNorvista CapitalN/AN/AN/AN/AN/AN/AN/AN/ARTIRTI International MetalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRIGRI Bio 3.00Buy$22.001,108.79% UpsideIMRiMetal Resources 0.00N/AN/AN/ANVVNorvista Capital 0.00N/AN/AN/ARTIRTI International Metals 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IMR, NVV, GRI, and RTI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025GRIGRI BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/27/2025GRIGRI BioAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $34.00(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRIGRI BioN/AN/AN/AN/A$7.68 per shareN/AIMRiMetal ResourcesN/AN/AC$0.05 per share3.51C$0.91 per shareN/ANVVNorvista Capital-C$1.27M-4.13C$0.12 per share0.63C$0.11 per share0.67RTIRTI International MetalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRIGRI Bio-$8.21M-$11.56N/AN/AN/AN/A-275.15%-168.22%8/12/2025 (Estimated)IMRiMetal Resources-C$2.26M-C$0.43N/A∞N/AN/A-37.31%-20.97%N/ANVVNorvista CapitalN/A-C$0.05N/A∞N/AN/AN/AN/AN/ARTIRTI International MetalsN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest IMR, NVV, GRI, and RTI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025GRIGRI Bio-$1.31N/AN/AN/AN/AN/A5/15/2025Q1 2025GRIGRI Bio-$4.08-$5.80-$1.72-$5.80N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGRIGRI BioN/AN/AN/AN/AN/AIMRiMetal ResourcesN/A3.01%N/AN/AN/ANVVNorvista CapitalN/AN/AN/AN/AN/ARTIRTI International MetalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRIGRI BioN/A1.411.41IMRiMetal Resources0.150.137.79NVVNorvista Capital0.0711.6211.58RTIRTI International MetalsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRIGRI Bio33.95%IMRiMetal ResourcesN/ANVVNorvista CapitalN/ARTIRTI International MetalsN/AInsider OwnershipCompanyInsider OwnershipGRIGRI Bio0.13%IMRiMetal Resources2.57%NVVNorvista CapitalN/ARTIRTI International MetalsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRIGRI Bio12.50 million2.49 millionNot OptionableIMRiMetal Resources1405.61 millionN/ANot OptionableNVVNorvista Capital1,99070.14 millionN/ANot OptionableRTIRTI International MetalsN/AN/AN/ANot OptionableIMR, NVV, GRI, and RTI HeadlinesRecent News About These CompaniesRTI International CEO on drastic funding cuts and his NC nonprofit’s market pivotJune 27, 2025 | msn.comLightstorm finishes integrating subsea cables bought from RTIMay 9, 2025 | datacenterdynamics.comDRTI INTERNATIONAL METALS (NYSE: RTI) - Share Price and ResearchMay 6, 2025 | intelligentinvestor.com.auIRTI International layoffs expected to reach at least 525 by May 1, organization saysMarch 27, 2025 | wral.comWRTI International layoff expected to reach at least 525 by May 1, organization saysMarch 27, 2025 | msn.comOpen Source: RTI International CEO makes seven figures. Does that justify USAID cuts?February 21, 2025 | msn.comRTI International to temporarily lay off staff due to US foreign aid freezeFebruary 14, 2025 | wunc.orgWRTI International lays off US workers, including in NC, citing Trump’s USAID cutsFebruary 13, 2025 | msn.comRTI International layoffs hit NC due to US freeze on foreign aidFebruary 13, 2025 | wral.comWResearch Urges Tyre Particles as Unique Eco ThreatNovember 14, 2024 | miragenews.comMA digital exam reels in engraved scenes of Stone Age net fishingNovember 7, 2024 | sciencenews.orgSRussia explores creation of international precious metals exchangeOctober 26, 2024 | msn.comRussia in talks with BRICS over precious metals exchangeOctober 24, 2024 | reuters.comRTI Joins the Common Vulnerabilities and Exposures (CVE®) Program as a CVE Numbering Authority (CNA)October 22, 2024 | markets.businessinsider.comRTI Awarded Elite Supplier Status by Lockheed Martin's Rotary and Mission Systems (RMS) DivisionOctober 15, 2024 | tmcnet.comAnalysts Conflicted on These Materials Names: Coeur Mining (CDE), RPM International (RPM) and Rio Tinto Limited (OtherRTNTF)October 10, 2024 | markets.businessinsider.comEnergy transition story rekindles fund interest in metalsOctober 7, 2024 | reuters.comJai Bhim Nagar Demolition: Mumbai Police To File FIR Against BMC Officers And PolicemenOctober 4, 2024 | msn.comRTI International Teams Up with USAID, UNICEF to Create a Lead-Free FutureOctober 4, 2024 | morningstar.comMMumbai: BMC Reveals Construction Of Two-Level Underground Parking Lot At Breach Candy In Response To RTI Amid Resident ConcernsOctober 3, 2024 | freepressjournal.inFNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIMR, NVV, GRI, and RTI Company DescriptionsGRI Bio NASDAQ:GRI$1.82 -0.13 (-6.67%) As of 07/18/2025 03:59 PM EasternGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.iMetal Resources CVE:IMRC$0.18 +0.01 (+5.88%) As of 07/18/2025 10:07 AM EasterniMetal Resources Inc., a junior exploration company, focuses on the acquisition, exploration, development, and evaluation of resource properties in Ontario and Quebec in Canada. The company explores for precious and base metal resources. Its flagship property is the Gowganda West project covering an area of approximately 147 squares kilometers located in Ontario; Kerrs Gold property covering an area of 665 hectares located in Ontario; and Ghost Mountain property consists of eleven claim units covering an area of 220 hectares located in Ontario. The company also holds 100% interest in the Carheil project encompasses approximately 5,400 acres of contiguous land located in the Abitibi region of Quebec. The company was formerly known as Adroit Resources Inc. and changed its name to iMetal Resources Inc. in November 2015. iMetal Resources Inc. was incorporated in 1993 and is headquartered in Vancouver, Canada.Norvista Capital CVE:NVVC$0.08 -0.01 (-6.25%) As of 01/12/2022Norvista Capital Corporation operates as a resource investment company and merchant bank in the United States and Canada. It invests in a portfolio of companies that are involved in the exploration of base and precious metals, such as copper, zinc, silver, gold, and lead, as well as oil and gas located in Chile, Manitoba, Yukon, Mexico, and Nevada; and oil and gas in Israel, the United States, Brazil, and Canada. The company was founded in 2014 and is headquartered in Toronto, Canada.RTI International Metals NYSE:RTIRTI International Metals, Inc. is a producer and global supplier of titanium mill products and a manufacturer of fabricated titanium and specialty metal components for the national and international aerospace, defense, energy, medical device, and other consumer and industrial markets. The Company operates in two segments: the Titanium segment and Engineered Products and Services (EP&S) segment. The Titanium Segment melts, processes, produces, forges, stocks, distributes, finishes, cuts-to-size, and facilitates just-in-time delivery services of a complete range of titanium mill products, which are further processed by its customers for use in a variety of commercial aerospace, defense, and industrial and consumer applications. The EP&S Segment is comprised of companies with significant hard and soft-metal expertise that form, extrude, fabricate, machine, additively manufacture, micro-machine, and assemble titanium, aluminum, and other specialty metal parts and components. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
